USD 0.09
(0.0%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | -18.3 Million |
Net Income | -1.46 Million | -848.29 Thousand | -959.14 Thousand | -11.67 Million | -1.43 Million | -618.2 Million |
Depreciation & Amortization | - | - | - | - | - | 162.5 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | 6.1 Million |
Change in working capital | - | - | - | - | - | -50.1 Million |
Other non-cash items | 1.46 Million | 848.29 Thousand | 959.14 Thousand | 11.67 Million | 1.43 Million | 145.2 Million |
Investing Cash Flow | - | - | - | - | - | -232.6 Million |
Investments in PPE | - | - | - | - | - | -244.8 Million |
Acquisitions | - | - | - | - | - | 6.7 Million |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | - | - | - | 11.3 Million |
Financing Cash Flow | - | - | - | - | - | 416.4 Million |
Debt repayment | - | - | - | - | - | -41.3 Million |
Dividends payments | - | - | - | - | - | -11.4 Million |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | - | - | - | - | -11.4 Million |
Accounts receivables | - | - | - | - | - | 23.4 Million |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | 228.4 Million |
Other working capital | - | - | - | - | - | 10.9 Million |
Cash at beginning of period | - | - | - | - | 239 Million | 68.4 Million |
Cash at end of period | - | - | - | - | 273.79 Thousand | 239 Million |
Capital Expenditure | - | - | - | - | - | -244.8 Million |
Effect of forex changes on cash | - | - | - | - | - | 5.1 Million |
Net cash flow / Change in cash | - | - | - | - | -238.72 Million | 170.6 Million |
Free Cash Flow | - | - | - | - | - | -263.1 Million |
Breakdown | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 38.78 | -1.46 Million | 38.78 | -770.56 | -770.56 | -848.29 Thousand |
Depreciation & Amortization | - | - | - | - | - | - |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | - | - | - | - | - |
Other non-cash items | -38.78 | 1.46 Million | -38.78 | 770.56 | 770.56 | 848.29 Thousand |
Investing Cash Flow | - | - | - | - | - | - |
Investments in PPE | - | - | - | - | - | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - | - |
Debt repayment | - | - | - | - | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | - | - | - | - | - |
Accounts receivables | - | - | - | - | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | - | - | - | - | - | - |
Cash at beginning of period | - | - | - | - | - | - |
Cash at end of period | - | - | - | - | - | - |
Capital Expenditure | - | - | - | - | - | - |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | - | - | - | - | - | - |
Free Cash Flow | - | - | - | - | - | - |
MOL
OPCT3
7134
ARBV
3202
OZK